This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guerrero, R. A.
Right arrow Articles by Estes, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guerrero, R. A.
Right arrow Articles by Estes, M. K.

 Previous Article  |  Next Article 

Journal of Virology, October 2001, p. 9713-9722, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9713-9722.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses

Roberto A. Guerrero,1,dagger Judith M. Ball,2,Dagger Sharon S. Krater,2 Susan E. Pacheco,1 John D. Clements,3 and Mary K. Estes2,4,*

Departments of Pediatrics,1 Molecular Virology and Microbiology,2 and Medicine-Gastroenterology,4 Baylor College of Medicine, Houston, Texas 77030, and Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, Louisiana 701123

Received 26 January 2001/Accepted 25 July 2001

Recombinant Norwalk virus-like particles (rNV VLPs) were administered to BALB/c mice by the intranasal (i.n.) route to evaluate the induction of mucosal antibody responses. The results were compared to systemic and mucosal responses observed in new and previous studies (J. M. Ball, M. E. Hardy, R. L. Atmar, M. E. Connor, and M. K. Estes, J. Virol. 72:1345-1353, 1998) after oral administration of rNV VLPs. Immunizations were given in the presence or absence of a mucosal adjuvant, mutant Escherichia coli heat-labile toxin LT(R192G). rNV-specific immunoglobulin G (IgG) and fecal IgA were evaluated by enzyme-linked immunosorbent assay. The i.n. delivery of rNV VLPs was more effective than the oral route at inducing serum IgG and fecal IgA responses to low doses of rNV particles. Vaginal responses of female mice given VLPs by the i.n. and oral routes were also examined. All mice that received two immunizations with low doses i.n. (10 or 25 µg) of rNV VLPs and the majority of mice that received two high doses orally (200 µg) in the absence of adjuvant had rNV-specific serum IgG, fecal, and vaginal responses. Additional experiments evaluated whether rNV VLPs can function as a mucosal adjuvant by evaluating the immune responses to two soluble proteins, keyhole limpet hemocyanin and chicken egg albumin. Under the conditions tested, rNV VLPs did not enhance the serum IgG or fecal IgA response to these soluble proteins when coadministered by the i.n. or oral route. Low doses of nonreplicating rNV VLPs are immunogenic when administered i.n. in the absence of adjuvant, and addition of adjuvant enhanced the magnitude and duration of these responses. Recombinant NV VLPs represent a candidate mucosal vaccine for NV infections in humans.


* Corresponding author. Mailing address: Division of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-3585. Fax: (713) 798-3586. E-mail: mestes{at}bcm.tmc.edu.

dagger Present address: Children's Gastroenterology of South Florida, West Palm Beach, FL 33470.

Dagger Present address: Department of Veterinary Pathobiology, Texas A & M University, College Station, TX 77843.


Journal of Virology, October 2001, p. 9713-9722, Vol. 75, No. 20
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.20.9713-9722.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Glass, R. I., Parashar, U. D., Estes, M. K. (2009). Norovirus Gastroenteritis. NEJM 361: 1776-1785 [Full Text]  
  • LoBue, A. D., Thompson, J. M., Lindesmith, L., Johnston, R. E., Baric, R. S. (2009). Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge. J. Virol. 83: 3212-3227 [Abstract] [Full Text]  
  • Chachu, K. A., Strong, D. W., LoBue, A. D., Wobus, C. E., Baric, R. S., Virgin, H. W. IV (2008). Antibody Is Critical for the Clearance of Murine Norovirus Infection. J. Virol. 82: 6610-6617 [Abstract] [Full Text]  
  • Buonaguro, L., Visciano, M. L., Tornesello, M. L., Tagliamonte, M., Biryahwaho, B., Buonaguro, F. M. (2005). Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation. J. Virol. 79: 7059-7067 [Abstract] [Full Text]  
  • Tamura, M., Natori, K., Kobayashi, M., Miyamura, T., Takeda, N. (2004). Genogroup II Noroviruses Efficiently Bind to Heparan Sulfate Proteoglycan Associated with the Cellular Membrane. J. Virol. 78: 3817-3826 [Abstract] [Full Text]  
  • Harrington, P. R., Vinje, J., Moe, C. L., Baric, R. S. (2004). Norovirus Capture with Histo-Blood Group Antigens Reveals Novel Virus-Ligand Interactions. J. Virol. 78: 3035-3045 [Abstract] [Full Text]  
  • Harrington, P. R., Lindesmith, L., Yount, B., Moe, C. L., Baric, R. S. (2002). Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice. J. Virol. 76: 12335-12343 [Abstract] [Full Text]  
  • Bertolotti-Ciarlet, A., White, L. J., Chen, R., Prasad, B. V. V., Estes, M. K. (2002). Structural Requirements for the Assembly of Norwalk Virus-Like Particles. J. Virol. 76: 4044-4055 [Abstract] [Full Text]  
  • Harrington, P. R., Yount, B., Johnston, R. E., Davis, N., Moe, C., Baric, R. S. (2002). Systemic, Mucosal, and Heterotypic Immune Induction in Mice Inoculated with Venezuelan Equine Encephalitis Replicons Expressing Norwalk Virus-Like Particles. J. Virol. 76: 730-742 [Abstract] [Full Text]